Sharemaestro Newsreel

DS World Las Vegas 2026 connects clinical and laboratory education

Dentsply Sirona World Las Vegas 2026 will offer a comprehensive educational program for dental professionals, connecting clinical expertise, laboratory innovation, and digital workflows to advance patient care. The event, taking place from September 24 to 26, will feature main stage presentations by clinical experts …

RBC Adjusts PT on Becton Dickinson and Co. to $190 From $180, Keeps Sector Perform Rating

RBC has increased its price target for Becton Dickinson and Co. (BDX) to $190 from $180, while maintaining a Sector Perform rating on the stock. This adjustment reflects RBC's updated outlook on the medical technology company. The article notes this update from MT Newswires.

West Pharmaceutical Services, Inc. $WST Stock Position Reduced by Handelsbanken Fonder AB

Handelsbanken Fonder AB has reduced its stake in West Pharmaceutical Services (NYSE:WST) by 14.8% in the second quarter, selling 8,535 shares. Despite this, institutional investors collectively own 93.9% of the company, which recently reported strong quarterly earnings exceeding analyst estimates. West Pharmaceutical Services also …

Handelsbanken Fonder AB Raises Stock Position in ResMed Inc. $RMD

Handelsbanken Fonder AB significantly increased its stake in ResMed Inc. by 36.6% in the second quarter, now holding 94,895 shares valued at $18.5 million. This move is part of broader institutional investor activity, with a collective 54.98% ownership, despite a mixed analyst sentiment and …

MMSI Maintained by B of A Securities -- Price Target Raised to $97.00

B of A Securities maintained a neutral rating on Merit Medical Systems (MMSI) but raised its price target from $92.00 to $97.00. GuruFocus indicates MMSI is undervalued by 4.9% with a strong GF Score of 86/100, excelling in growth and valuation. While gurus show …

Becton, Dickinson and Company $BDX Shares Purchased by Handelsbanken Fonder AB

Handelsbanken Fonder AB increased its stake in Becton, Dickinson and Company (NYSE:BDX) by 32.7% in the second quarter, now owning 170,572 shares valued at $25.81 million. Other institutional investors like Auto Owners Insurance Co and Vanguard Group Inc. also significantly modified their holdings. Insider …

Weekly Earnings Wrap: CBA, REA Group, Westpac, Resmed and more

This article provides a weekly wrap-up of earnings season, focusing on major Australian companies like CBA, REA Group, Westpac, ResMed, and Life360. It highlights varying performances, with REA Group benefiting from property market changes and ResMed showing resilient growth despite missed guidance. The report …

Royal Bank of Canada Grows Stock Position in Stevanato Group S.p.A. $STVN

Royal Bank of Canada increased its stake in Stevanato Group S.p.A. (NYSE:STVN) by 15.8% in the first quarter, now holding 421,696 shares valued at approximately $5.8 million. Other institutional investors like Conestoga Capital Advisors, T. Rowe Price, Norges Bank, and Credit Agricole also expanded …

First Trust Advisors LP Reduces Stock Position in Teleflex Incorporated $TFX

First Trust Advisors LP significantly reduced its stake in Teleflex Incorporated by 98.4% in Q1 2026, selling over 161,000 shares but retaining a small position. Despite this, institutional investors still hold a substantial 95.62% of the company's stock. Teleflex reported strong Q2 earnings, beating …

Renaissance Technologies LLC Lowers Stock Position in ICU Medical, Inc. $ICUI

Renaissance Technologies LLC significantly reduced its stake in ICU Medical, Inc. by 68.8% in the first quarter, selling 24,991 shares and retaining 11,309 shares worth $1.46 million. Despite this reduction, institutional investors collectively own 96.1% of the company, which recently exceeded quarterly earnings and …

BNP Paribas Exane cuts Alcon stock rating on competitive pressure

BNP Paribas Exane downgraded Alcon Inc. to Neutral from Outperform, citing competitive pressures in its intraocular lens business and difficult comparisons in the Instruments segment. The firm also lowered its price target, anticipating that new products won't significantly improve growth until early to mid-2027. …

Avantor, Inc. $AVTR Shares Purchased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly increased its stake in Avantor, Inc. (NYSE:AVTR) by 425% in the second quarter, acquiring an additional 450,801 shares, bringing its total holdings to 556,871 shares valued at approximately $5.5 million. This purchase contributes to institutional investors collectively owning 95.08% …

14-Day Rally Sends Merit Medical Systems Stock Up 25%

The article "14-Day Rally Sends Merit Medical Systems Stock Up 25%" indicates a significant recent increase in the stock value of Merit Medical Systems. However, the provided content is largely boilerplate and does not contain the actual article details regarding this rally. It primarily …

ResMed Inc. Stock 12‑Month Price Target Cut to $258.47, Implies 14% Upside

The average 12-month price target for ResMed Inc. (RMD) stock has been revised down slightly to $258.47 from $261.36, as estimated by 22 analysts. This new target suggests a potential 14% upside from the Aug. 12 closing price. The consensus rating among 29 analysts …

Bank of America Corp DE Boosts Stock Holdings in ICU Medical, Inc. $ICUI

Bank of America Corp DE significantly increased its stake in ICU Medical, Inc. by 11.2% in the first quarter, now holding 331,739 shares valued at $42.8 million. This comes as ICU Medical exceeded Q2 earnings expectations, reporting EPS of $2.37 and revenue of $547.88 …

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Consensus Recommendation of "Hold" by Analysts

Kestra Medical Technologies (NASDAQ:KMTS) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $28.14, aligning closely with its current stock price. Despite missing quarterly earnings estimates, the company's stock opened at $28.00, and analysts project a full-year loss …

The 5 Most Interesting Analyst Questions From ICU Medical’s Q2 Earnings Call

ICU Medical (ICUI) reported strong Q2 CY2026 results, exceeding analyst expectations for revenue, adjusted EPS, and EBITDA, driven by robust performance in Infusion Systems and Consumables. The article highlights key analyst questions from the earnings call, focusing on the drivers of Infusion Systems growth, …

Align Technology Wins Patent Dispute Against Angelalign in China; Angelalign Plans to Appeal

Align Technology has won a patent infringement lawsuit against Angelalign Technology in China, with the Jinan Intermediate People’s Court ordering Angelalign to cease sales of certain products and pay RMB 10 million in damages. Angelalign plans to appeal the decision, asserting that its products …

The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q2 Earnings Call

Dentsply Sirona (XRAY) reported Q2 CY2026 earnings, exceeding analyst expectations for revenue and adjusted EPS, though shares declined post-announcement. Management attributed revenue decline to lower sales in key segments and regions, noting the company is in a "turnaround" phase with uneven improvements. Analysts focused …

Align Technology, Inc. (ALGN) Stock Forecasts

Argus has lowered its target price for Align Technology (ALGN), the leading manufacturer of clear aligners, to $194.00. The company's main product, Invisalign, holds over 90% of the market share. The current stock price for ALGN is $174.01.

Jim Cramer’s Surprise AI Pick: Aramark (ARMK)

Jim Cramer has spent months tracking the expanding ripple effects of the artificial intelligence infrastructure boom. He has repeatedly pointed out how secondary beneficiaries are emerging in unexpected places. The theme took center stage when he highlighted Aramark (NYSE:ARMK) after the food services and …

STAAR Surgical Q2 Sales Surge, Fueled by China as Key Market

STAAR Surgical (NASDAQ: STAA) announced significant Q2 2026 financial results, with net sales reaching $93.5 million, an 111 percent increase year-over-year. This surge was primarily driven by the Chinese market, which accounted for over half of the quarterly revenue. The company also reported improvements …

Intuitive Surgical (ISRG): 3 Reasons We Love This Stock

Despite a recent 17.5% stock price decline, Intuitive Surgical (ISRG) is highlighted as a compelling investment due to its strong long-term revenue growth of 16.4% annually, outstanding EPS growth of 17.4% annually over five years, and an expanding free cash flow margin which currently …

Form 8K Bausch & Lomb Corp For: 12 August By Investing.com

This article reports on the filing of Form 8K by Bausch & Lomb Corp (BLCO) for August 12. It includes a brief mention of the company's stock performance, noting a 1.31% increase. The content primarily consists of navigational elements, market data tables, and trending …

AtriCure, Inc. - Common Stock (ATRC) Stock Price, News, Quote & History

This page provides a comprehensive overview of AtriCure, Inc. (ATRC) stock, including its current price, key financial metrics, and recent news. AtriCure is a medical device company specializing in treatments for atrial fibrillation and other cardiac conditions, focusing on minimally invasive surgical procedures. The …

Pomona hospital upgrades its surgical robots

Pomona Valley Hospital Medical Center has upgraded its surgical robot system by acquiring three of the latest Intuitive da Vinci 5 surgical systems. This new fleet of technology offers improved resolution, more realistic 3D imaging, and applies significantly less force on tissue, benefiting patients …

Why STAAR Surgical (STAA) Is Getting Fresh Attention Now

Bausch + Lomb (NYSE:BLCO) CAO Sells 52,900 Shares

Bausch + Lomb's Chief Accounting Officer, Frederick Munsch, sold 52,900 shares of the company's stock for approximately $887,662, reducing his direct holdings by over 53%. The transaction occurred on Monday, August 10th, and was disclosed in an SEC filing. Despite the insider sale, BLCO …

Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny

STAAR Surgical (NASDAQ:STAA) Releases Quarterly Earnings Results, Misses Estimates By $0.06 EPS

BioLife Solutions, Inc. (BLFS) Stock Forecasts

Argus has raised its target price for BioLife Solutions Inc. (BLFS) to $37.00. The company, a life sciences firm, specializes in bioproduction products and services aimed at enhancing quality and mitigating risks in biologic manufacturing, distribution, and transportation within the cell and gene therapy …

Bausch & Lomb (BLCO) SVP Frederick Munsch sells 52,900 shares in August trade

Frederick Munsch, SVP, Controller and CAO of Bausch & Lomb Corp (BLCO), sold 52,900 common shares on August 10, 2026, at a weighted average price of $16.78 per share. The sales occurred in multiple trades ranging from $16.73 to $16.85, leaving him with 45,831 …

The Real Price of Intuitive Surgical Stock's Robotic Future

Align Technology (ALGN): Capital World Investors reports 5% beneficial stake

Capital World Investors, a division of Capital Research and Management Company, has reported a beneficial ownership of 3,571,496 shares of Align Technology, Inc. common stock, which represents 5.0% of the company's outstanding shares. The filing indicates that Capital World Investors holds sole voting power …

Becton Dickinson (NYSE: BDX) EVP Roland Goette sells 2,438 shares at $180.84

Becton Dickinson's EVP and President, EMEA, Roland Goette, sold 2,438 shares of common stock at $180.84 per share on August 11, 2026. These shares were acquired through the company's Global Share Investment Program. Following the sale, Goette directly holds 14,856 shares and indirectly holds …

Intuitive Surgical (ISRG) Beats On Q2 As Investors Ask If The Bull Case Is Priced In

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Intuitive Surgical (ISRG) shook investors after reporting strong Q2 2026 revenue and earnings that beat expectations, while revealing slower U.S. procedure growth and …